- Leadership - Neurocrine Biosciences
Johanna Mercier has served on the Board of Directors since April 2021 Ms Mercier serves as the Chief Commercial Officer of Gilead Sciences, overseeing the global commercialization of the company’s medicines across virology, oncology and inflammation
- Neurocrine Biosciences - Leadership Team - The Org
The Leadership Team at Neurocrine Biosciences drives the strategic vision and operational excellence necessary to fulfill the company's mission of relieving suffering through innovative neuroscience therapies
- Neurocrine Biosciences Incs Chief Commercial Officer Eric Benevich . . .
On February 13, 2024, Eric Benevich, Chief Commercial Officer of Neurocrine Biosciences Inc (NASDAQ:NBIX), executed a sale of 1,098 shares of the company
- Neurocrine Biosciences Inc. Company Profile Executives - WSJ
Company profile for Neurocrine Biosciences Inc including key executives, insider trading, ownership, revenue and average growth rates View detailed NBIX description address
- Neurocrine Biosciences, Inc. Appoints Eric Benevich as Chief Commercial . . .
Neurocrine Biosciences Inc announced that Eric Benevich has joined the company as Chief Commercial Officer Mr Benevich was most recently at Avanir Pharmaceuticals as Vice President of Marketing where he was responsible for NUEDEXTA® and commercialization of their CNS pipeline
- Neurocrine Biosciences, Inc. Announces Appointment of Eric Benevich as . . .
"We are very pleased to welcome Eric to the Neurocrine team as our Chief Commercial Officer," said Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences
- Eric S Benevich, Neurocrine Biosciences Inc: Profile and Biography
Eric S Benevich is Chief Commercial Officer at Neurocrine Biosciences Inc See Eric S Benevich's compensation, career history, education, memberships
- Neurocrine Biosciences Executive Team - Comparably
Mr Eric S Benevich has been the Chief Commercial Officer at Neurocrine Biosciences Inc since May 26, 2015 Mr
|